64
46. Huber, M.M., Ternes, T.A., Von Gunten, U. (2004) Removal of estrogenic
activity and formation of oxidation produtcs during ozonation of 17α-
ethinylestradiol. Environ Sci Technol 38, 5177-5186.
47. Jarnheimer, P-Å., Ottoson, J., Linderg, R., Stenströn, T-A., Johansson, M.,
Tysklind, M., Winner, M-M., Olsen, B. (2004) Fluoroquinolone antibiotics in
a hospital sewage line; occurence, distribution and impact on bacterial
resistence. Scand J Infect Dis (36) 752-755.
48. Joss, A., Keller, E., Alder, A.C., Göbel, A., McArdell, C.S., Ternes, T.,
Siegrist, H. (2005) Removal of pharmaceuticals and fragrances in biological
wastewater treatment. Water Res 39, 3139-3152.
49. Karthikeyan, K.G., Meyer, M.T. (2006) Occurrence of antibiotics in
wastewater treatment facilities in Wisconsin, USA. Sci Total Environ 361,
196-207.
50. Katzung, B.G. (1995) Farmacologia básica e clínica. Guanabara Koogan, 6°
Ed. Rio de Janeiro, p516.
51. Katzung, B.G. (1995) Farmacologia básica e clínica. Guanabara Koogan, 6°
Ed. Rio de Janeiro, p565.
52. Kolpin, D.W., Furlong, E.T., Meyer, M.T., Thurman, E.M., Zaugg, S.D.,
Barber, L.B., Buxton, H.T. (2002) Pharmaceuticals, hormones, and other
organics wastewater contaminants in U.S. streams, 1999-2000: a national
reconnaissance. Environ Sci Technol 36, 1202-1211.
53. Kolpin, D.W., Skopec, M., .Meyer, M.T., Furlong, E.T., Zaugg, S.D. (2004)
Urban contribution of pharmaceuticals and other organic wastewater
contaminants to streams during differing flow conditions. Sci Tot Environ
328, 119-130.
54. Kümmerer, K. (2001) Drugs in the environment: emission of drugs,
diagnostics aids and disinfectants into wastewater by hospitals in relation to
other sources - a review. Chemosphere 45, 957-969.
55. Kümmerer, K. (2001) Pharmaceuticals in the environment: sources, fate,
effects and Risks, Springer-Verlag Berlin Heidelberg, 1° ed., Germany, p 5.